0001062993-23-020118.txt : 20231103 0001062993-23-020118.hdr.sgml : 20231103 20231103183453 ACCESSION NUMBER: 0001062993-23-020118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelderman Kim CENTRAL INDEX KEY: 0001739054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 231377714 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-11-01 0000842023 BIO-TECHNE Corp TECH 0001739054 Kelderman Kim 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 Chief Operating Officer 0 Common Stock 2023-11-01 4 A 0 14196 0 A 35421 D Stock Option (Right to Buy) 37.70 2025-05-01 Common Stock 27392 27392 D Stock Option (Right to Buy) 44.33 2025-08-08 Common Stock 84308 84308 D Stock Option (Right to Buy) 47.60 2026-08-07 Common Stock 109536 109536 D Stock Option (Right to Buy) 66.97 2027-08-05 Common Stock 69264 69264 D Stock Option (Right to Buy) 66.97 2027-08-05 Common Stock 47952 47952 D Restricted Stock Units Common Stock 4980 4980 D Stock Option (Right to Buy) 120.46 2028-08-06 Common Stock 19456 19456 D Stock Option (Right to Buy) 120.46 2028-08-06 Common stock 25944 25944 D Restricted Stock Units Common Stock 6984 6984 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 21704 21704 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 28940 28940 D Restricted Stock Units Common Stock 8191 8191 D Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 22043 22043 D Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 29391 29391 D Stock Options (Right to Buy) 52.83 2023-11-01 4 A 0 38252 0 A 2030-11-01 Common Stock 38252 38252 D Represents 14,196 shares of restricted stock for which risks of forfeiture lapse as to 4,732 shares on each of 11/1/2024, 11/1/2025 and 11/1/2026. Fully exercisable. Options to purchase 35,964 shares are vested. Options to purchase 11,988 shares vest on 8/5/2024. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,236 shares are vested. Options to purchase 7,236 shares vest on each of 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed. 2023-11-03